Blog

Friday Market Insights – Rising rates and lack of Fed clarity is causing volatility

blue background with cash and creadit card and hand holding a timing clock
Partager sur Facebook
Faire un tweet
Partager sur LinkedIn

Watch Friday Market Insights – Rising rates and lack of Fed clarity is causing volatility, with Ian Lusher and Mike Thiessen

Horodatage

[00:00:00] Intro

[00:00:23] : What happened in the markets this week?

[00:01:05] : Due to the market movements, what have we done inside our portfolios? And is there anything in particular that we did this week in terms of adjustments?

[00:02:25] : Can you explain to our clients why exactly the bond market is reacting the way it is right now?

[00:04:27] : The Johnson and Johnson vaccine has been approved in the US. How much of a big deal is this one shot vaccine? So what do you think the overall impact long term to the economy will be from this particular vaccine?

[00:06:44] : Is Canada being left in kind of an unenviable position economically due to this lagged vaccine vaccination plan?

Ian Lusher : [00:00:04] Welcome, everybody, to our Friday Market Insights. My name’s Ian Lusher. I’m a partner and portfolio manager at Genus Capital Management, and I’m joined by Mike Thiessen, who is also a partner, and he is our director of Sustainable Investing. So, Mike, we’ll get right into it.

 

Mike Thiessen : [00:00:22] Sure.

 

Ian Lusher : [00:00:23] What happened in the markets this week?

 

Mike Thiessen : [00:00:26] Yes, so this week was a very volatile week. A lot of movement happening in the S&P 500 is down, around one percent on the TSX is is flat to slightly on the week as of right now. And we’re reporting things can change. So the big news this week is the US 10 year yields continue to increase. And this is due to kind of the renormalization of the economy, some fears of inflation and the Federal Reserve really not doing too much about that. But we can get more into that later. So a lot of movement, but the market’s not really going one direction very strongly yet.

 

Ian Lusher : [00:01:05] Due to the market movements, what have we done inside our portfolios? And is there anything in particular that we did this week in terms of adjustments?

 

Mike Thiessen : [00:01:14] Yeah, yeah. So we have been making adjustments in clients portfolios, especially around kind of the the renormalization of the economy and around technology. So we have been taking technology down and a lot of portfolios to a more neutral stance. And we’ll be doing that even more throughout this next week as well as we rebalance a lot of our portfolios. Technology in our models isn’t it looking as attractive as before and with with rates going with rates going up, then the overall valuations of these of these tech companies aren’t quite as attractive as before. So we’re taking some technology kind of off the table, being more neutral. And then we’re we’ve for a while, we’ve had some weight in companies that would do quite well in an economic recovery. But we’re we’re adding to those weights. So adding to areas like financials, like materials, like industrials. And so this is really the kind of economic reopening where we’re seeing that the economic reopening is going to continue.

 

Ian Lusher : [00:02:16] Exactly. So you alluded earlier to the reaction, reaction in the bond market and, you know, the yields going up. Can you explain to our clients why exactly the bond market is reacting the way it is right now?

 

Mike Thiessen : [00:02:34] Sure, yeah, so so yields are rising because of the kind of the renormalization of the economy and people are seeing the economic recovery happening and then there’s also fears of inflation. And so when investors see that, then they think that there could be a tightening of the monetary policy, which means that rates could be going up by by central banks around the world, especially the Fed and the Fed and Powell have been kind of waffling on the whole situation, not really giving any clear guidance. So that’s creating more uncertainty around around the markets. And when this happens, that also affects the equity market, certain parts of the equity market. So certain companies do quite well during a reopening or during times when when rates go up. But then other sectors like technology rely so much on this cheap capital, especially right now, that they haven’t been doing well, just the prospect of rates going up. And so much of these tech companies valuation is based on the value of their future cash flows that might be five years out, 10 years out. And so when rates go up, then then you have to discount these future cash flows by these higher rates, which brings down the overall value of those companies. And so ultimately, tech companies evaluation is going down. And we saw the Nasdaq really crash this week. And so that’s really overpowering these other industries that aren’t doing too well and are actually.

 

Ian Lusher : [00:03:58] Yeah, I mean, what’s happening right now is actually quite healthy for our clients in terms of we have a portfolio approach so we don’t have everything in one in one basket. So having this happen this week is very good for people in a portfolio approach because we have quite a bit of exposure to those areas that have kind of been ignored up until maybe even the last week or two.

 

Mike Thiessen : [00:04:24] Yeah.

 

Ian Lusher : [00:04:25] We talked about this previously. The Johnson and Johnson vaccine has been approved in the US. It’s now approved in Canada. How much of a big deal is this one shot vaccine? And also the fact that they’ve made a deal in the States with Merck to help produce. So what do you think the overall impact long term to the economy will be from this particular vaccine?

 

Mike Thiessen : [00:04:50] Yeah, I think there’s going to have a big effect on on the economy in the short run and long run for Canada and the US, I think that, of course, it’s great to get more vaccines going for health and well-being, of course, of the country. But then also just to get get get more of these industries back online that have been that have been off for so long. And the Jayjay vaccine is special because there’s only a one shot vaccine. So that’s good from a logistical perspective, because you only need to have that one shot. You don’t need to figure out where you’re going to have the second shot of that same vaccine. And and then on the production front, if you’re producing one hundred thousand of these JMJ vaccines, that means that one hundred or a hundred thousand people can get vaccinated versus if you’re doing that for Fizer or Moderna, that where you need two shots, that means only fifty thousand people can get vaccinated if you’re making one hundred thousand. So on the on the production front, it’s great. And yeah, and they’ve signed an agreement with Merck to help produce even more of this vaccine. So ultimately, I think that’s going to be great for the economy. The JJ vaccine isn’t as effective as as the Pfizer or Moderna I think it’s sixty six percent effective, but it’s about 80 percent effective or more for the more severe cases. So those are really the ones that we want to be stopping. We want to be lowering the hospitalization rate and of course the death rate around the virus.

 

Ian Lusher : [00:06:11] I mean, the simple answer is one shot is better than two and more vaccines is always better. More options is better.

 

Mike Thiessen : [00:06:18] Yeah.

 

Ian Lusher : [00:06:19] The US markets, particularly some of the southern states, Texas, Mississippi, they’re making a push to fully open up. They’re actually completely ending their market mandate. Part of this is due to declining numbers. And part of it some of it’s political. But really the end result of this is due to higher vaccination rates in the US versus say, what we’re seeing here in Canada is Canada being left in kind of an unenviable position economically due to this lagged vaccine vaccination plan?

 

Mike Thiessen : [00:06:53] Yeah, I think Canada is is going to be falling behind economically because of this. We’re going to be we’re going to be opening much later than other areas of the world like the US. And that, of course, does hurt our economy. It hurts people that are out of jobs that that are really relying on this recovery happening in Canada right now. I think it’s about five or six percent of the population is vaccinated versus about twenty five percent in the US. So there’s a really big difference there. And we’re not going to be to go into mass immunizations of people under 65 until July. And there probably isn’t going to be enough supply for us until July or sometime in the summer as well. So I think once the US finishes most of their vaccinations and areas of Europe, there’s going to be a lot of supply of these vaccinations. So I think that will probably happen kind of late summer, early fall. So then we’ll have so much supply. It’s just going to be a matter of figuring out how to do these mass immunizations with the general population.

 

Ian Lusher : [00:07:52] Thank you very much for that answer. And we’ve got we’re out of time, so thanks everyone for watching again. Have a great weekend and take care.

 

Mike Thiessen : [00:08:01] Thank you.

 

Facebook
Twitter
LinkedIn
Courriel

Client impact

"Passer d'une grande banque à Genus a été l'une des meilleures décisions financières que nous ayons jamais prises. Genus a assuré une croissance fiable des actifs malgré notre tolérance modérée au risque. Alors que notre sécurité financière s'est accrue, nous avons également bénéficié d'une excellente expérience client. Les communications de la société ont toujours été transparentes et informatives, y compris les webinaires éducatifs et un portail Web bien conçu où nous pouvons suivre nos investissements quotidiennement. Le plus important pour nous est que notre gestionnaire de portefeuille a toujours répondu rapidement et de manière exhaustive à nos questions et à nos demandes. "
Martin T.
"Ayant des objectifs et des besoins financiers relativement divers, ainsi qu'une légère réticence à l'égard du marché boursier, Genus a habilement répondu à toutes nos préoccupations et a mis au point un plan vraiment exceptionnel : Des fonds sans combustibles fossiles et un portefeuille d'investissement diversifié, oui ; un portefeuille d'investissement à impact efficace qui coïncide avec nos espoirs et nos rêves d'un monde meilleur, oui ; des conseils et une assistance professionnels pour créer un fonds de bienfaisance conseillé par le donateur avec des reçus de bienfaisance immédiats à des fins fiscales, oui. Les résultats ? Bien au-delà de nos espérances ! Nous nous sommes même amusés en cours de route et nous avons certainement profité d'un incroyable départ de deux ans pour ce qui sera une relation satisfaisante à long terme avec Genus.
Marc B.
"J'aime le service que je reçois chez Genus.
Chris H.
"Leslie et moi étions membres du même conseil d'administration lorsque nous nous sommes rencontrés il y a vingt ans. Au cours des dix dernières années, elle a réfléchi à l'élaboration d'une stratégie d'investissement pour ma famille et l'a mise en œuvre comme prévu. L'équipe de Genus a répondu à mes attentes et c'est un plaisir de traiter avec elle".
Bob Q.
"Pendant plus de 15 ans, j'ai assuré la sélection et l'évaluation des performances de plusieurs gestionnaires d'investissement pour un important family office. Leslie et Genus ont joué un rôle fondamental dans ma fonction. J'ai toujours trouvé que Leslie et ses collègues étaient perspicaces et proactifs, et que la performance de leur part du portefeuille était bien supérieure aux indices de référence. Et c'est un grand plaisir de travailler avec eux".
Douglas H.
"Genus est une société très innovante. Je suis heureux d'investir dans leurs stratégies Fossil Free et Impact qui m'aident à investir en accord avec mes valeurs."
Marnie C.
"Excellente équipe de professionnels. Site web et rapports excellents. Répond rapidement aux demandes de renseignements. Je suis également très satisfait du processus de changement d'une autre société à Genus. Bravo !".
David L.
"Genus fournit toujours une bonne image, clairement expliquée et complète de la situation économique et financière générale, ainsi qu'un excellent compte-rendu des décisions d'investissement prises en fonction de cette situation. L'intérêt tout aussi marqué de Genus pour les questions et les demandes d'informations complémentaires de ses clients est également un élément très important du service qu'il fournit".
Allan S.
"En 1992, lorsque je me suis retrouvé à cinquante ans avec une somme d'argent importante à investir, je ne savais qu'une chose : je ne voulais pas contribuer aux compagnies de tabac, aux fabricants d'armes ou aux compagnies pétrolières. Mais au cours des années qui ont suivi, les options d'investissement socialement responsable sont devenues beaucoup plus sophistiquées et je suis très heureux que cela fasse partie intégrante de l'approche de Genus. J'apprécie également beaucoup la relation à long terme avec ma gestionnaire de portefeuille, Mary Lou.
Ann P.

Comme vu dans

Prêt.e à avoir un impact avec vos investissements?

Appelez-nous
Appelez-nous
1-800-668-7366

Ou remplissez vos coordonnées et nous vous contacterons.